Doxycycline vs Tofacitinib

Doxycycline vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Doxycycline and Tofacitinib.

Mechanism of Action

Doxycycline: Inhibits bacterial protein synthesis by binding 30S ribosomal subunit.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Doxycycline — 18-22 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Doxycycline — C22H24N2O8; Tofacitinib — C16H20N6O.

Molecular Weight: Doxycycline — 444.4350 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Doxycycline — Small molecule; Tofacitinib — Small molecule.